Quarterly report pursuant to Section 13 or 15(d)

SHARE CAPITAL

v3.22.2.2
SHARE CAPITAL
 9 Months Ended
Sep. 30, 2022
Equity [Abstract]  
SHARE CAPITAL

9. SHARE CAPITAL

 

   

Nine months ended September 30,

2022

  
    # of shares    

Amount

  
Common shares issued for bonuses and compensation     184,563     $ 432,054  
Common shares issued for conversion of convertible debt     67,568       131,532  
Common shares issued to consultants     259,767       801,457  
Total common shares issued     511,898     $ 1,365,043  

 

    Nine months ended September 30, 2021  
    # of shares     Amount  
Common shares issued for cash     3,127,998     $ 13,262,712  
Common shares issued for conversion of series A preferred stock     2,258,826       6,717,873  
Common shares issued on exercise of warrants     39,800       238,800  
Common shares issued on cashless exercise of options     820,029       -  
Common shares issued for bonus     98,356       514,066  
Common shares issued for consulting services     62,237       349,809  
Common shares issued for settlement of accrued director’s fee     19,992       46,783  
Common shares issued for dividend on preferred shares     189,004       735,932  
Share issue costs     -       (2,099,842 )
Total common shares issued     6,616,242     $ 19,766,133  

 

Potentially dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive are as follows (in common equivalent shares):

 

   

September 30,

2022

    

September 30,

2021

  
Warrants     9,876,680       5,864,200  
Options     635,569       724,037  
Convertible debentures     5,744,595       -  
Total anti-dilutive weighted average shares     16,256,844       6,588,237